<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00641433</url>
  </required_header>
  <id_info>
    <org_study_id>ORT 014</org_study_id>
    <nct_id>NCT00641433</nct_id>
  </id_info>
  <brief_title>Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails</brief_title>
  <official_title>Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rosalind Franklin University of Medicine and Science</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rosalind Franklin University of Medicine and Science</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study's purpose is to prospectively determine whether topical therapy with an oxidized
      regenerated cellulose collagen-silver compound is more effective than the current standard of
      topical antibiotic therapy for care following the removal of an ingrown toenail. Eighty adult
      patients with ingrown toenails will be recruited. Each patient will randomly be assigned to
      apply either topical silver sulfadiazine cream (standard antibiotic) or the novel
      collagen-silver compound to their nail bed daily, following removal of the ingrown portion of
      nail. Patients will return for follow up visits weekly, until healing has occurred or twelve
      weeks have passed. Healing will be defined as resolution of drainage and inflammatory changes
      surrounding the nail border.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2005</start_date>
  <completion_date type="Anticipated">May 2008</completion_date>
  <primary_completion_date type="Anticipated">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to healing</measure>
    <time_frame>weekly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to return to regular shoe gear</measure>
    <time_frame>weekly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days unable to work</measure>
    <time_frame>weekly</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Ingrown Nail</condition>
  <arm_group>
    <arm_group_label>experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will daily dress their nail bed with oxidized regenerated cellulose collagen-silver, until healing occurs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical silver sulfadiazine cream will be applied daily to the wound bed until healing has occured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>oxidized regenerated cellulose collagen-silver</intervention_name>
    <description>Wound dressed daily with oxidized regenerated cellulose collagen-silver matrix.</description>
    <arm_group_label>experimental</arm_group_label>
    <other_name>Prisma</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical silver sulfadiazine cream</intervention_name>
    <description>Cream will be applied to nailbed daily and dressed with a bandage until healing occurs.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Silvadene, Thermazene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ingrown toenails will be defined as any incurvated nail border that digs into the skin
             of the nail fold and causes pain and discomfort

        Exclusion Criteria:

          -  Patients with immunocompromised states

               -  chronic steroid use

               -  diabetes mellitus

               -  collagen vascular disease

               -  HIV infection

          -  Cellulitis proximal to the hallux interphalangeal joint or peripheral vascular disease
             will be excluded

          -  We will define peripheral vascular disease as the absence of one or more pedal pulses
             or the presence of dystrophic changes to the integument
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David G Armstrong, DPM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rosalind Franklin University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David G Armstrong, DPM, PhD</last_name>
    <phone>847-578-8440</phone>
    <email>david.armstrong@rosalindfranklin.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Scholl Foot and Ankle Center</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan T Crews, MS</last_name>
      <phone>847-578-8437</phone>
      <email>ryan.crews@rosalindfranklin.edu</email>
    </contact>
    <investigator>
      <last_name>David Armstrong, DPM, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Wu, DPM, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Wrobel, DPM, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Preofessional Education and Research Institutue</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Zelen, DPM</last_name>
      <phone>540-725-5027</phone>
      <email>cmzelen@periedu.com</email>
    </contact>
    <investigator>
      <last_name>Charles Zelen, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2008</study_first_submitted>
  <study_first_submitted_qc>March 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2008</study_first_posted>
  <last_update_submitted>March 18, 2008</last_update_submitted>
  <last_update_submitted_qc>March 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2008</last_update_posted>
  <responsible_party>
    <name_title>Office of Sponsored Research</name_title>
    <organization>Rosalind Franklin University of Medicine and Science</organization>
  </responsible_party>
  <keyword>chemocautery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nails, Ingrown</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulfadiazine</mesh_term>
    <mesh_term>Silver Sulfadiazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

